TreVita, a U.S.-based medical travel company, announced that its four-year partnership with Sundance Medical Financing has supported millions of dollars in financed procedures for clients seeking care abroad. The milestone, reported by NEWMEDIAWIRE, underscores how flexible payment options are reshaping access to elective medical procedures performed outside the United States.
The program covers a range of services, including plastic surgery, bariatric surgery, stem cell treatments and other regenerative procedures. In 2026, Sundance Medical Financing approved 99% of TreVita clients who applied for financing, with credit decisions returned in less than one business day. Clients can choose repayment terms of 24 or 36 months, allowing them to spread a portion of their procedure costs over time.
More than one-third of TreVita clients choose to finance through Sundance Medical Financing. Among financed procedures, loans cover an average of 60% of the total procedure cost, granting access to care that was otherwise not possible in many cases, according to the company.
“TreVita is focused on removing obstacles so that people can access the medical care they deserve. Offering the ability to finance medical care through Sundance Medical Financing plays a major role unlocking access to everyday Americans,” said Blake Schroder, CEO of TreVita. “Over the past four years, Sundance has become an important part of how we remove barriers to care that many of our customers had initially thought out of reach.”
The implications extend beyond one company. Medical travel, often marketed as a lower-cost alternative to domestic care, has historically required upfront payment, limiting its reach to consumers with ready cash. By integrating financing directly into the client experience, TreVita and Sundance are lowering that barrier and potentially expanding the addressable market for overseas providers. Sundance Medical Financing serves applicants across credit profiles and offers competitive rates based on credit qualifications, which the company says are generally lower than otherwise available in the marketplace.
“TreVita’s results show the value of making financing a straightforward part of the client experience,” said John Jodka, Director of Lending for Sundance Medical Financing. “Businesses want to serve clients with a wide range of financial backgrounds, and clients want options that fit their circumstances. Our partnership brings those needs together, helping TreVita support more clients while giving them greater flexibility in how they pay.”
TreVita facilitates medical travel by helping clients navigate provider selection, procedure coordination and travel logistics. Headquartered in San Diego, the company connects clients with carefully vetted physicians abroad, with services spanning plastic surgery, bariatric surgery, hair restoration and regenerative medicine. Its coordinated approach gives clients a dedicated team from initial inquiry through return home. Financing through Sundance complements those services by addressing another part of the planning process: how clients will pay for their chosen procedure.
For readers considering medical travel, the partnership signals that financing is becoming a standard feature of the sector, potentially making procedures more accessible but also adding a credit obligation that should be weighed carefully. For the industry, the 99% approval rate and one-business-day decisions set a benchmark for how financing can be embedded in medical travel platforms. More details on TreVita’s financing options are available at https://www.trevita.com/financing/, and businesses interested in offering Sundance Medical Financing can visit https://sundancemedicalfinancing.com/. Financing is subject to credit approval, and the 99% approval rate reflects applications submitted in 2026 through October 31 and does not guarantee future approval.
